The sensitivity of muscle force predictions to changes in physiologic cross-sectional area.

The mechanical effects of a muscle are related in part to the size of the muscle and to its location relative to the joint it crosses. For more than a century, researchers have expressed muscle size by its 'physiological cross-sectional area' (PCSA). Researchers mathematically calculating muscle and joint forces typically use some expression of a muscle's PCSA to constrain the solution to one which is reasonable (i.e. a solution in which small muscles may not have large forces, and large muscles have large forces when expected or when there is significant electromyographic activity). It is obvious that muscle mass (and therefore any expression of PCSA) varies significantly from person to person, even in individuals of similar weight and height. Since it is not practical to predict the PCSA of each muscle in a living subject's limb or trunk, it is important to generally understand the sensitivity of muscle force solutions to possible variations in PCSA. We used nonlinear optimization techniques to predict 47 muscle forces and hip contact forces in a living subject. The PCSA (volume/muscle fiber length) of each of 47 lower limb muscle elements from two cadaver specimens and the 47 PCSA's reported by pierrynowski were input into an optimization algorithm to create three solution sets. The three solutions were qualitatively similar but at times a predicted muscle force could vary as much as two to eight times. In contrast, the joint force solutions were within 11% of each other and, therefore, much less variable.(ABSTRACT TRUNCATED AT 250 WORDS)

Sodium nitroprusside: twenty years and counting.

SNP remains an effective, reliable, and commonly used drug for the rapid reduction of significant arterial hypertension regardless of the etiology, for afterload reduction in the face of low CO when blood volume is normal or increased, and for intraoperative induced hypotension. After establishing indwelling arterial monitoring, an initial infusion rate of 0.3-0.5 micrograms.kg-1.min-1 is begun with titration as needed up to 2.0 micrograms.kg-1.min-1. Higher rates for brief periods of time (10 min) are acceptable. The use of alternative drugs to reduce the dose or shorten the duration of infusion should be considered when the 2.0 micrograms.kg-1.min-1 range is exceeded (Table 1). SNP should not be used by individuals unfamiliar with its potency and metabolic pathways, as the many reports of adverse reactions testify. Careful attention to infusion rates, particularly in patients at risk for depleted thiosulfate stores, is mandatory, and the use of other drugs in conjunction with or instead of SNP should always be considered. As with many therapeutic interventions, SNP requires careful administration to appropriately selected patients by a clinician who knows its inherent hazards. Despite its toxicity, SNP is popular because it is often the most (in some cases, the only) effective drug in some difficult clinical circumstances.

Anesthetic management of a massively morbidly obese patient.

BACKGROUND AND OBJECTIVES: A 408-kg patient presented for surgical resection of a lower extremity mass. METHODS: A specially designed bed and well-planned transport were used to deliver the patient to the operating room suite. The anesthetic technique included a continuous subarachnoid catheter with tetracaine and epinephrine. Intraoperative monitoring consisted of electrocardiography, pulse oximetry, intraarterial blood pressure, and mental status examinations. Massive intraoperative hemorrhage was treated with rapid volume infusions and vasopressors. RESULTS: Resection of a lower extremity mass was accomplished and the patient was eventually discharged from the hospital. CONCLUSIONS: The case report emphasizes that prior planning of all aspects of patient care is important in massively morbidly obese patients and that regional anesthesia is a valuable option in these patients.